Back to Rheumatology

OUR EXPERTISE AND SERVICES AVAILABLE IN

Lupus

Overview

Spherix’s coverage of the systemic lupus erythematosus market focuses on rheumatologists’ understanding, diagnosis, and treatment of the disease. Learnings include brand use, factors in brand selection and criteria for evaluating success.

Services Available

Exploring the patient journey

  • Lupus Nephritis (US) - n=1,000 patient charts

  • Systemic Lupus Erythematosus (US) - n=1,000 patient charts

Prepping for the pipeline

  • Lupus Nephritis (US)

  • Systemic Lupus Erythematosus (US)

Benchmarking new brand performance

  • Anifrolumab (AstraZeneca) in Systemic Lupus Erythematosus (US)*

  • Benlysta (GSK) and Lupkynis (Aurinia) in Lupus Nephritis (US)

*Pending approvals and launch

Gauging impact of disruptive events

  • Multi-Specialty Impact of COVID-19 (US)

Learn more about our services

  • HOW CAN WE PARTNER TOGETHER?

    Get more information on Lupus Coverage